nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—migraine—Prednisone—Crohn's disease	0.468	0.508	CpDpCtD
Cyclobenzaprine—osteoarthritis—Prednisone—Crohn's disease	0.453	0.492	CpDpCtD
Cyclobenzaprine—HTR2A—enteric nervous system—Crohn's disease	0.00529	0.467	CbGeAlD
Cyclobenzaprine—HTR2A—myenteric nerve plexus—Crohn's disease	0.00401	0.354	CbGeAlD
Cyclobenzaprine—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00225	0.033	CcSEcCtD
Cyclobenzaprine—Cholestasis—Mercaptopurine—Crohn's disease	0.002	0.0294	CcSEcCtD
Cyclobenzaprine—Tongue discolouration—Mesalazine—Crohn's disease	0.0017	0.025	CcSEcCtD
Cyclobenzaprine—Tongue oedema—Mesalazine—Crohn's disease	0.00147	0.0216	CcSEcCtD
Cyclobenzaprine—Bone marrow depression—Azathioprine—Crohn's disease	0.00134	0.0197	CcSEcCtD
Cyclobenzaprine—Bone marrow depression—Mesalazine—Crohn's disease	0.00122	0.0179	CcSEcCtD
Cyclobenzaprine—Cholestasis—Azathioprine—Crohn's disease	0.00119	0.0175	CcSEcCtD
Cyclobenzaprine—Tongue disorder—Mesalazine—Crohn's disease	0.00113	0.0166	CcSEcCtD
Cyclobenzaprine—Cholestasis—Mesalazine—Crohn's disease	0.00108	0.0159	CcSEcCtD
Cyclobenzaprine—Withdrawal symptom—Prednisone—Crohn's disease	0.00106	0.0156	CcSEcCtD
Cyclobenzaprine—Acne—Mesalazine—Crohn's disease	0.000978	0.0144	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Mercaptopurine—Crohn's disease	0.000903	0.0133	CcSEcCtD
Cyclobenzaprine—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.000888	0.0131	CcSEcCtD
Cyclobenzaprine—Stomatitis—Mercaptopurine—Crohn's disease	0.000827	0.0122	CcSEcCtD
Cyclobenzaprine—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00075	0.011	CcSEcCtD
Cyclobenzaprine—Hypertonia—Mesalazine—Crohn's disease	0.000721	0.0106	CcSEcCtD
Cyclobenzaprine—Alopecia—Mercaptopurine—Crohn's disease	0.000673	0.0099	CcSEcCtD
Cyclobenzaprine—Disorientation—Mesalazine—Crohn's disease	0.000668	0.00982	CcSEcCtD
Cyclobenzaprine—Libido decreased—Mesalazine—Crohn's disease	0.000644	0.00948	CcSEcCtD
Cyclobenzaprine—Thirst—Mesalazine—Crohn's disease	0.000628	0.00923	CcSEcCtD
Cyclobenzaprine—Delusion—Prednisone—Crohn's disease	0.000615	0.00905	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Mesalazine—Crohn's disease	0.000597	0.00879	CcSEcCtD
Cyclobenzaprine—Leukopenia—Mercaptopurine—Crohn's disease	0.000593	0.00873	CcSEcCtD
Cyclobenzaprine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.000593	0.00872	CcSEcCtD
Cyclobenzaprine—Face oedema—Mesalazine—Crohn's disease	0.000577	0.00848	CcSEcCtD
Cyclobenzaprine—Oedema—Mercaptopurine—Crohn's disease	0.000541	0.00796	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Azathioprine—Crohn's disease	0.000538	0.00792	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00053	0.00779	CcSEcCtD
Cyclobenzaprine—Gastritis—Mesalazine—Crohn's disease	0.000529	0.00778	CcSEcCtD
Cyclobenzaprine—Acne—Prednisone—Crohn's disease	0.000517	0.00761	CcSEcCtD
Cyclobenzaprine—Anorexia—Mercaptopurine—Crohn's disease	0.000516	0.00758	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Mesalazine—Crohn's disease	0.000511	0.00752	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000493	0.00725	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Mesalazine—Crohn's disease	0.00049	0.00721	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00048	0.00706	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Mesalazine—Crohn's disease	0.000477	0.00702	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Azathioprine—Crohn's disease	0.000472	0.00694	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Mercaptopurine—Crohn's disease	0.00047	0.00692	CcSEcCtD
Cyclobenzaprine—Weight increased—Mesalazine—Crohn's disease	0.00047	0.00691	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000451	0.00664	CcSEcCtD
Cyclobenzaprine—Stomatitis—Mesalazine—Crohn's disease	0.000449	0.0066	CcSEcCtD
Cyclobenzaprine—Jaundice—Mesalazine—Crohn's disease	0.000449	0.0066	CcSEcCtD
Cyclobenzaprine—Sweating—Mesalazine—Crohn's disease	0.000441	0.00649	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Mesalazine—Crohn's disease	0.00043	0.00632	CcSEcCtD
Cyclobenzaprine—Hepatitis—Mesalazine—Crohn's disease	0.000413	0.00608	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Mesalazine—Crohn's disease	0.00041	0.00603	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Azathioprine—Crohn's disease	0.000405	0.00596	CcSEcCtD
Cyclobenzaprine—Alopecia—Azathioprine—Crohn's disease	0.000401	0.0059	CcSEcCtD
Cyclobenzaprine—HTR2A—epithelium—Crohn's disease	0.000399	0.0352	CbGeAlD
Cyclobenzaprine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000399	0.00586	CcSEcCtD
Cyclobenzaprine—CYP1A2—digestive system—Crohn's disease	0.000388	0.0343	CbGeAlD
Cyclobenzaprine—Tinnitus—Mesalazine—Crohn's disease	0.000385	0.00567	CcSEcCtD
Cyclobenzaprine—HTR2A—smooth muscle tissue—Crohn's disease	0.000384	0.0339	CbGeAlD
Cyclobenzaprine—Euphoric mood—Prednisone—Crohn's disease	0.000374	0.0055	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00037	0.00544	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Azathioprine—Crohn's disease	0.000366	0.00539	CcSEcCtD
Cyclobenzaprine—Alopecia—Mesalazine—Crohn's disease	0.000365	0.00537	CcSEcCtD
Cyclobenzaprine—Malaise—Azathioprine—Crohn's disease	0.000356	0.00524	CcSEcCtD
Cyclobenzaprine—Flatulence—Mesalazine—Crohn's disease	0.000355	0.00521	CcSEcCtD
Cyclobenzaprine—Leukopenia—Azathioprine—Crohn's disease	0.000354	0.0052	CcSEcCtD
Cyclobenzaprine—Vascular purpura—Prednisone—Crohn's disease	0.000353	0.0052	CcSEcCtD
Cyclobenzaprine—Tension—Mesalazine—Crohn's disease	0.000353	0.00519	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Mesalazine—Crohn's disease	0.000352	0.00518	CcSEcCtD
Cyclobenzaprine—Nervousness—Mesalazine—Crohn's disease	0.000349	0.00514	CcSEcCtD
Cyclobenzaprine—Vomiting—Mercaptopurine—Crohn's disease	0.000344	0.00506	CcSEcCtD
Cyclobenzaprine—Rash—Mercaptopurine—Crohn's disease	0.000341	0.00502	CcSEcCtD
Cyclobenzaprine—Dermatitis—Mercaptopurine—Crohn's disease	0.000341	0.00501	CcSEcCtD
Cyclobenzaprine—Vision blurred—Mesalazine—Crohn's disease	0.000339	0.00499	CcSEcCtD
Cyclobenzaprine—Tremor—Mesalazine—Crohn's disease	0.000337	0.00496	CcSEcCtD
Cyclobenzaprine—Myalgia—Azathioprine—Crohn's disease	0.000336	0.00495	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Mesalazine—Crohn's disease	0.000334	0.00491	CcSEcCtD
Cyclobenzaprine—Discomfort—Azathioprine—Crohn's disease	0.000332	0.00489	CcSEcCtD
Cyclobenzaprine—Angioedema—Mesalazine—Crohn's disease	0.000329	0.00484	CcSEcCtD
Cyclobenzaprine—Purpura—Prednisone—Crohn's disease	0.000328	0.00482	CcSEcCtD
Cyclobenzaprine—Malaise—Mesalazine—Crohn's disease	0.000324	0.00477	CcSEcCtD
Cyclobenzaprine—Vertigo—Mesalazine—Crohn's disease	0.000323	0.00475	CcSEcCtD
Cyclobenzaprine—Syncope—Mesalazine—Crohn's disease	0.000323	0.00475	CcSEcCtD
Cyclobenzaprine—Leukopenia—Mesalazine—Crohn's disease	0.000322	0.00474	CcSEcCtD
Cyclobenzaprine—Nausea—Mercaptopurine—Crohn's disease	0.000321	0.00473	CcSEcCtD
Cyclobenzaprine—Palpitations—Mesalazine—Crohn's disease	0.000318	0.00468	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Mesalazine—Crohn's disease	0.000316	0.00465	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Prednisone—Crohn's disease	0.000316	0.00465	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Azathioprine—Crohn's disease	0.000316	0.00464	CcSEcCtD
Cyclobenzaprine—Hypertension—Mesalazine—Crohn's disease	0.000311	0.00457	CcSEcCtD
Cyclobenzaprine—Psychotic disorder—Prednisone—Crohn's disease	0.000309	0.00454	CcSEcCtD
Cyclobenzaprine—Chest pain—Mesalazine—Crohn's disease	0.000306	0.00451	CcSEcCtD
Cyclobenzaprine—Myalgia—Mesalazine—Crohn's disease	0.000306	0.00451	CcSEcCtD
Cyclobenzaprine—Anxiety—Mesalazine—Crohn's disease	0.000305	0.00449	CcSEcCtD
Cyclobenzaprine—Face oedema—Prednisone—Crohn's disease	0.000305	0.00449	CcSEcCtD
Cyclobenzaprine—HTR2A—digestive system—Crohn's disease	0.000304	0.0268	CbGeAlD
Cyclobenzaprine—Discomfort—Mesalazine—Crohn's disease	0.000303	0.00445	CcSEcCtD
Cyclobenzaprine—Irritability—Prednisone—Crohn's disease	0.000302	0.00444	CcSEcCtD
Cyclobenzaprine—Hypotension—Azathioprine—Crohn's disease	0.000301	0.00443	CcSEcCtD
Cyclobenzaprine—Dry mouth—Mesalazine—Crohn's disease	0.0003	0.00441	CcSEcCtD
Cyclobenzaprine—Confusional state—Mesalazine—Crohn's disease	0.000296	0.00435	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000294	0.00432	CcSEcCtD
Cyclobenzaprine—Oedema—Mesalazine—Crohn's disease	0.000294	0.00432	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Mesalazine—Crohn's disease	0.000294	0.00432	CcSEcCtD
Cyclobenzaprine—Shock—Mesalazine—Crohn's disease	0.000289	0.00425	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000287	0.00423	CcSEcCtD
Cyclobenzaprine—Tachycardia—Mesalazine—Crohn's disease	0.000287	0.00421	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000284	0.00417	CcSEcCtD
Cyclobenzaprine—CYP3A4—digestive system—Crohn's disease	0.000281	0.0248	CbGeAlD
Cyclobenzaprine—Anorexia—Mesalazine—Crohn's disease	0.00028	0.00412	CcSEcCtD
Cyclobenzaprine—CYP2D6—digestive system—Crohn's disease	0.000276	0.0244	CbGeAlD
Cyclobenzaprine—Hypotension—Mesalazine—Crohn's disease	0.000274	0.00404	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000268	0.00393	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Azathioprine—Crohn's disease	0.000266	0.00391	CcSEcCtD
Cyclobenzaprine—Insomnia—Mesalazine—Crohn's disease	0.000266	0.00391	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Mesalazine—Crohn's disease	0.000264	0.00388	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000264	0.00388	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Mesalazine—Crohn's disease	0.000262	0.00385	CcSEcCtD
Cyclobenzaprine—Somnolence—Mesalazine—Crohn's disease	0.000261	0.00384	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Mesalazine—Crohn's disease	0.000258	0.0038	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Mesalazine—Crohn's disease	0.000255	0.00375	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Azathioprine—Crohn's disease	0.000255	0.00375	CcSEcCtD
Cyclobenzaprine—Fatigue—Mesalazine—Crohn's disease	0.000253	0.00372	CcSEcCtD
Cyclobenzaprine—Erectile dysfunction—Prednisone—Crohn's disease	0.000252	0.0037	CcSEcCtD
Cyclobenzaprine—Constipation—Mesalazine—Crohn's disease	0.000251	0.00369	CcSEcCtD
Cyclobenzaprine—Weight increased—Prednisone—Crohn's disease	0.000249	0.00366	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Mesalazine—Crohn's disease	0.000242	0.00356	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00024	0.00353	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00024	0.00353	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Prednisone—Crohn's disease	0.000239	0.00351	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Prednisone—Crohn's disease	0.000239	0.00351	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Azathioprine—Crohn's disease	0.000237	0.00349	CcSEcCtD
Cyclobenzaprine—Urticaria—Mesalazine—Crohn's disease	0.000233	0.00343	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Mesalazine—Crohn's disease	0.000232	0.00341	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Azathioprine—Crohn's disease	0.000221	0.00324	CcSEcCtD
Cyclobenzaprine—Hallucination—Prednisone—Crohn's disease	0.000218	0.0032	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Mesalazine—Crohn's disease	0.000216	0.00318	CcSEcCtD
Cyclobenzaprine—Dizziness—Azathioprine—Crohn's disease	0.000213	0.00314	CcSEcCtD
Cyclobenzaprine—Asthenia—Mesalazine—Crohn's disease	0.000211	0.0031	CcSEcCtD
Cyclobenzaprine—Pruritus—Mesalazine—Crohn's disease	0.000208	0.00306	CcSEcCtD
Cyclobenzaprine—Vomiting—Azathioprine—Crohn's disease	0.000205	0.00301	CcSEcCtD
Cyclobenzaprine—Rash—Azathioprine—Crohn's disease	0.000203	0.00299	CcSEcCtD
Cyclobenzaprine—Dermatitis—Azathioprine—Crohn's disease	0.000203	0.00299	CcSEcCtD
Cyclobenzaprine—Headache—Azathioprine—Crohn's disease	0.000202	0.00297	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Mesalazine—Crohn's disease	0.000201	0.00295	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Prednisone—Crohn's disease	0.000195	0.00287	CcSEcCtD
Cyclobenzaprine—Dizziness—Mesalazine—Crohn's disease	0.000194	0.00286	CcSEcCtD
Cyclobenzaprine—Alopecia—Prednisone—Crohn's disease	0.000193	0.00284	CcSEcCtD
Cyclobenzaprine—Nausea—Azathioprine—Crohn's disease	0.000191	0.00282	CcSEcCtD
Cyclobenzaprine—Vomiting—Mesalazine—Crohn's disease	0.000187	0.00275	CcSEcCtD
Cyclobenzaprine—Rash—Mesalazine—Crohn's disease	0.000185	0.00272	CcSEcCtD
Cyclobenzaprine—Dermatitis—Mesalazine—Crohn's disease	0.000185	0.00272	CcSEcCtD
Cyclobenzaprine—Headache—Mesalazine—Crohn's disease	0.000184	0.00271	CcSEcCtD
Cyclobenzaprine—Vision blurred—Prednisone—Crohn's disease	0.000179	0.00264	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Prednisone—Crohn's disease	0.000177	0.0026	CcSEcCtD
Cyclobenzaprine—Agitation—Prednisone—Crohn's disease	0.000175	0.00257	CcSEcCtD
Cyclobenzaprine—Nausea—Mesalazine—Crohn's disease	0.000174	0.00257	CcSEcCtD
Cyclobenzaprine—Angioedema—Prednisone—Crohn's disease	0.000174	0.00256	CcSEcCtD
Cyclobenzaprine—Malaise—Prednisone—Crohn's disease	0.000172	0.00252	CcSEcCtD
Cyclobenzaprine—Vertigo—Prednisone—Crohn's disease	0.000171	0.00252	CcSEcCtD
Cyclobenzaprine—Syncope—Prednisone—Crohn's disease	0.000171	0.00251	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Prednisone—Crohn's disease	0.000167	0.00246	CcSEcCtD
Cyclobenzaprine—Convulsion—Prednisone—Crohn's disease	0.000165	0.00243	CcSEcCtD
Cyclobenzaprine—Hypertension—Prednisone—Crohn's disease	0.000164	0.00242	CcSEcCtD
Cyclobenzaprine—Myalgia—Prednisone—Crohn's disease	0.000162	0.00238	CcSEcCtD
Cyclobenzaprine—Anxiety—Prednisone—Crohn's disease	0.000161	0.00238	CcSEcCtD
Cyclobenzaprine—Discomfort—Prednisone—Crohn's disease	0.00016	0.00235	CcSEcCtD
Cyclobenzaprine—Oedema—Prednisone—Crohn's disease	0.000155	0.00228	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Prednisone—Crohn's disease	0.000155	0.00228	CcSEcCtD
Cyclobenzaprine—Shock—Prednisone—Crohn's disease	0.000153	0.00225	CcSEcCtD
Cyclobenzaprine—Tachycardia—Prednisone—Crohn's disease	0.000152	0.00223	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Prednisone—Crohn's disease	0.00015	0.00221	CcSEcCtD
Cyclobenzaprine—Anorexia—Prednisone—Crohn's disease	0.000148	0.00218	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000142	0.00208	CcSEcCtD
Cyclobenzaprine—Insomnia—Prednisone—Crohn's disease	0.000141	0.00207	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Prednisone—Crohn's disease	0.000139	0.00205	CcSEcCtD
Cyclobenzaprine—Imipramine—SLC22A4—Crohn's disease	0.000137	0.4	CrCbGaD
Cyclobenzaprine—Dyspepsia—Prednisone—Crohn's disease	0.000137	0.00201	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—SLC22A5—Crohn's disease	0.000136	0.398	CrCbGaD
Cyclobenzaprine—Decreased appetite—Prednisone—Crohn's disease	0.000135	0.00199	CcSEcCtD
Cyclobenzaprine—Fatigue—Prednisone—Crohn's disease	0.000134	0.00197	CcSEcCtD
Cyclobenzaprine—Constipation—Prednisone—Crohn's disease	0.000133	0.00195	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Prednisone—Crohn's disease	0.000128	0.00188	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Prednisone—Crohn's disease	0.000127	0.00187	CcSEcCtD
Cyclobenzaprine—Urticaria—Prednisone—Crohn's disease	0.000123	0.00182	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Prednisone—Crohn's disease	0.000123	0.00181	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Prednisone—Crohn's disease	0.000114	0.00168	CcSEcCtD
Cyclobenzaprine—Asthenia—Prednisone—Crohn's disease	0.000111	0.00164	CcSEcCtD
Cyclobenzaprine—Pruritus—Prednisone—Crohn's disease	0.00011	0.00162	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Prednisone—Crohn's disease	0.000106	0.00156	CcSEcCtD
Cyclobenzaprine—Dizziness—Prednisone—Crohn's disease	0.000103	0.00151	CcSEcCtD
Cyclobenzaprine—Vomiting—Prednisone—Crohn's disease	9.88e-05	0.00145	CcSEcCtD
Cyclobenzaprine—Rash—Prednisone—Crohn's disease	9.79e-05	0.00144	CcSEcCtD
Cyclobenzaprine—Dermatitis—Prednisone—Crohn's disease	9.79e-05	0.00144	CcSEcCtD
Cyclobenzaprine—Headache—Prednisone—Crohn's disease	9.73e-05	0.00143	CcSEcCtD
Cyclobenzaprine—Nausea—Prednisone—Crohn's disease	9.23e-05	0.00136	CcSEcCtD
Cyclobenzaprine—Nortriptyline—ALB—Crohn's disease	4.09e-05	0.119	CrCbGaD
Cyclobenzaprine—Amitriptyline—ALB—Crohn's disease	2.84e-05	0.0828	CrCbGaD
